Biosite, Beckman, Eksigent, New Zealand Scientific, Proteome Sciences, Onconome, Power3, Viventia, Penn State | GenomeWeb
Proposed Biosite-Beckman Merger Clears Antitrust Hurdle
Biosite said this week that the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had expired without a request from the US Federal Trade Commission for additional information about Biosite’s proposed merger with Beckman Coulter, removing one hurdle from the $1.55 billion deal to proceed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.